Forbes April 29, 2024
There’s never been a worse time to get sick in Canada. Our northern neighbors must wait 2.5 years longer than Americans enrolled in Medicare to access new drugs, according to a report published this month by the Canadian Health Policy Institute.
The Canadian government has chosen to deprive its citizens of the latest therapies by dictating the prices drug makers must abide by if they want access to the Canadian market. And now, the Biden administration and several states are looking to deploy Canadian-style tactics here at home.
When public officials levy price controls on prescription drugs, they’re putting the government’s finances ahead of patients’ lives.
Drug companies understandably prioritize selling in markets where they can make the most progress...
Today's Sponsors
Today's Sponsor